![Gerhard Bauer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerhard Bauer
Direktor/Vorstandsmitglied bei
Sitem-Insel AG
Profil
Gerhard Bauer is currently a Director at Sitem-Insel AG and Swiss Medtech.
Previously, he worked as the VP-Global Operations & Engineering Officer at Bausch & Lomb, Inc. He also worked as a Portfolio Manager at Raiffeisen Kapitalanlage-Gesellschaft mbH from 2002 to 2006.
From 2010 to 2020, he was the Head-Research, Development & Operations at Straumann Holding AG.
He also worked as a Principal at GlaxoSmithKline, Inc. Dr. Bauer holds a graduate and doctorate degree from Ludwig-Maximilians-Universität München.
Aktuelle Nachrichten zu Gerhard Bauer
Aktive Positionen von Gerhard Bauer
| Unternehmen | Position | Beginn |
|---|---|---|
Sitem-Insel AG | Direktor/Vorstandsmitglied | - |
Swiss Medtech
 Swiss Medtech Miscellaneous Commercial ServicesCommercial Services Operates as an industry association that represents the medical technology sector | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Gerhard Bauer
| Unternehmen | Position | Ende |
|---|---|---|
| STRAUMANN HOLDING AG | Geschäftsführer | 01.05.2020 |
Raiffeisen Kapitalanlage-Gesellschaft mbH
 Raiffeisen Kapitalanlage-Gesellschaft mbH Investment ManagersFinance Raiffeisen KAG believes that capital markets are not efficient. During their asset allocation process, their asset managers work in teams to develop and implement investment strategies, aiming to outperform the average market yield. Qualitative and quantitative analysis is the core of the firm's management approach. A team of in-house analysts use a bottom-up approach for equities and a top-down approach for fixed-income and umbrella fund investments. | Portfolio Manager-Aktien | 26.09.2006 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Geschäftsführer | - |
Ausbildung von Gerhard Bauer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
46
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Health Technology |
Raiffeisen Kapitalanlage-Gesellschaft mbH
Raiffeisen Kapitalanlage-Gesellschaft mbH Investment ManagersFinance Raiffeisen KAG believes that capital markets are not efficient. During their asset allocation process, their asset managers work in teams to develop and implement investment strategies, aiming to outperform the average market yield. Qualitative and quantitative analysis is the core of the firm's management approach. A team of in-house analysts use a bottom-up approach for equities and a top-down approach for fixed-income and umbrella fund investments. | Finance |
Straumann Holding AG
 Straumann Holding AG Medical SpecialtiesHealth Technology Develops, produces and markets products for dental implants and biomaterials for soft and hard tissue generation | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sitem-Insel AG | |
Swiss Medtech
Swiss Medtech Miscellaneous Commercial ServicesCommercial Services Operates as an industry association that represents the medical technology sector | Commercial Services |
